February 5, 2014
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- /
BACK for Discussion: SUMMARY: Background Patients who develop relapsing-remitting multiple sclerosis (MS) present with a first clinical demyelinating event. In…
